āĻšā§āĻŽTKPHF âĸ OTCMKTS
add
Takeda Pharmaceutical Co Ltd
⧍ā§.ā§Ŧā§Ļ$
āĻāĻŖā§āĻāĻž āĻĒāϰā§:(ā§Ž.ā§Ģā§Ģ%)+⧍.ā§Šā§Ŧ
⧍⧝.⧝ā§Ŧ$
āĻŦāύā§āϧ āĻāĻā§: ā§Ģ āĻā§āύ, ā§Ē:ā§§ā§Ē:ā§Ģ⧝ PM GMT -ā§Ē · USD · OTCMKTS · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āϏā§āĻāĻāĻŽāĻžāϰā§āĻāĻŋāύ āϝā§āĻā§āϤāϰāĻžāώā§āĻā§āϰ-āĻ āϤāĻžāϞāĻŋāĻāĻžāĻā§āĻā§āϤ āϏāĻŋāĻāĻŋāĻāϰāĻŋāĻāĻŋ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
ā§¨ā§Ž.ā§Ļā§Š$
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
⧍ā§.ā§Ŧā§Ļ$ - ⧍ā§.ā§Ŧā§Ļ$
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§¨ā§Š.ā§Žā§Ļ$ - ā§Šā§¨.ā§§ā§Š$
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
ā§Ēā§Ŧ.ā§Žā§ĢāĻļāĻ¤Â āĻā§ USD
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
ā§§ā§Ļ.ā§¯ā§§Â āĻšāĻž
P/E āĻ
āύā§āĻĒāĻžāϤ
-
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
-
āĻĒā§āϰāĻžāĻāĻŽāĻžāϰāĻŋ āĻāĻā§āϏāĻā§āĻā§āĻ
TYO
āĻāĻŦāϰ⧠āϰā§ā§āĻā§
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
(JPY) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ā§§.ā§Ļā§Ģ āϞāĻž.āĻā§. | ā§Ļ.⧍ā§Ē% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§Ŧā§ā§¯.ā§Žā§ĻāĻā§ | ā§§ā§§.ā§Ļā§Ģ% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | -ā§§ā§Ļā§Š.⧍ā§ĻāĻā§ | -ā§Š,ā§Šā§§ā§¯.ā§Ēā§Ž% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | -⧝.ā§Žā§Ļ | -ā§Š,⧍ā§ā§¯.ā§Šā§§% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | â | â |
EBITDA | ā§§ā§Žā§§.⧍ā§āĻā§ | ā§§ā§.ā§¨ā§Ž% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ā§Š.⧝⧧% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(JPY) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ā§Šā§Žā§Ģ.ā§§ā§§āĻā§ | -ā§§ā§Ģ.ā§Žā§Ž% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§§ā§Ē.⧍ā§Ģ āϞāĻž.āĻā§. | -ā§Ģ.ā§ā§Ļ% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§.ā§Šā§§Â āϞāĻž.āĻā§. | -ā§Ŧ.ā§Ŧā§% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Ŧ.⧝ā§Ē āϞāĻž.āĻā§. | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§§ā§Ģā§Ž.ā§Ģā§¨Â āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§Ļ.ā§Ļā§§ | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | -ā§Ļ.ā§§ā§Ē% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | -ā§Ļ.ā§§ā§% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
(JPY) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | -ā§§ā§Ļā§Š.⧍ā§ĻāĻā§ | -ā§Š,ā§Šā§§ā§¯.ā§Ēā§Ž% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | ⧍⧍⧍.ā§§ā§ŦāĻā§ | -⧍ā§Ļ.⧍ā§Ŧ% |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -⧧⧝.ā§Ŧā§ŽāĻļāĻ¤Â āĻā§ | ā§Ŧā§.⧝⧝% |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§Šā§Ļā§§.ā§ā§¯āĻā§ | -ā§Ēā§§ā§Ž.ā§Šā§Ē% |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | -ā§§ā§Ļ⧝.ā§Ļā§§āĻā§ | -ā§§ā§Ŧā§Ē.ā§Šā§Ē% |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| ā§§ā§ā§¯.ā§Ēā§ŦāĻā§ | ⧧⧍.ā§Ŧ⧝% |
āϏāĻŽā§āĻĒāϰā§āĻā§
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. Wikipedia
āϏāĻŋāĻāĻ
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
⧧⧍ āĻā§āύ, ā§§ā§ā§Žā§§
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§Ē⧝,ā§¨ā§Žā§§